Moreover, the restoration of microglia phagocytic function by the injected anti-IL17 antibodies inhibited early Aβ accumulation in these mice, indicating that pathogenic Th17 cells differentiated by the activated plasma ASM/ceramide pathway play a critical role in acceleration of AD brain pathology in young AD mice. This evidence concerns the gene IL17A and Alzheimer disease.